missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cilostazol Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR15031G
Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Cilostazol is a dihydro-quinolinone derivative, that is predominantly used as an anti-platelet and vasodilatory agent. It acts by inhibition of cyclic adenosine monophosphate (cAMP) phosphodiesterase, which results in elevation of cAMP levels in platelets and blood vessels, thus inhibiting platelets aggregation. Featured Industries: Pharmaceutical (small molecule)Specifications
| 73963-72-1 | |
| C20H27N5O2 | |
| Cilostazol; 6-[4-(1-Cyclohexyl-1 H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1 H)-quinolinone; OPC 13013; OPC 21; Pletaal | |
| 1 g | |
| Certified Reference Material |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00866780 | |
| Certified Reference Material | |
| 369.46 |